Puresta launches EVERQ, AI-powered skin-health platform

Puresta Lifestyle Private Limited announced the launch of EVERQ, an AI-powered skin-health platform designed to bring skin assessment, dermatologist consultations, personalised treatment and ongoing skincare together in one connected journey.

EVERQ is part of Puresta’s integrated skin-health ecosystem, which also includes SKINQ Rx and SKINQ. EVERQ serves as the consumer-facing platform connecting AI-led skin assessment with dermatologist-led care. SKINQ Rx provides targeted, dermatologist-led treatment solutions based on the consultation, while SKINQ extends the experience into clinically validated everyday and maintenance skincare.

The platform is being developed with a focus on Indian and melanin-rich skin, recognising that concerns such as pigmentation, acne, sensitivity and post-inflammatory marks can present differently across skin types. Puresta combines technology, dermatological expertise and data-led formulation as part of its approach to personalised skin health, with a focus on moving consumers away from generic product recommendations and towards solutions based on their individual skin needs.

With EVERQ, Puresta aims to move skincare from a primarily product-led experience towards a more personalised and outcome-led model. Rather than treating a consultation, prescription and skincare purchase as separate transactions, the platform is designed to retain context across the consumer’s care journey. As a consumer’s skin changes, the care journey can evolve with it.

The digital-first model also aims to make dermatologist-led skincare more accessible beyond India’s largest cities, reducing geography as a barrier to professional skin care.

Hitaysh Dhingraa, co-founder & CEO, Puresta, said: “India doesn’t have a skincare discovery problem. It has a diagnosis problem. Consumers have thousands of products and millions of recommendations, but very little clarity on what their skin actually needs. We built EVERQ around a simple philosophy — Diagnose First. Then Treat. AI helps us understand consumers and their skin at scale, dermatologists bring clinical judgement, and our ecosystem helps take that care from assessment through treatment and ongoing skincare. We don’t want to sell consumers more skincare. We want to help them use the right skincare.”

  • Related Posts

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell interventions that have not been approved for routine clinical use, including those offered for autism, should not be provided as routine, standard or commercial clinical services, the advisory…

    US FDA launches expedited IND Pilot, begins accepting applications

    The US Food and Drug Administration (FDA) announced the final design of the Expedited Investigational New Drug (IND) Pilot. Accelerating clinical trial timelines and eliminating regulatory hurdles to maintain American…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Puresta launches EVERQ, AI-powered skin-health platform

    Puresta launches EVERQ, AI-powered skin-health platform

    Stem cell therapy for autism only in approved clinical trials: Centre

    Stem cell therapy for autism only in approved clinical trials: Centre

    US FDA launches expedited IND Pilot, begins accepting applications

    US FDA launches expedited IND Pilot, begins accepting applications

    PIL in SC seeks time-bound probe, stringent action against fake drug networks

    PIL in SC seeks time-bound probe, stringent action against fake drug networks

    Ghaziabad: Fake supplement racket busted, 5 held

    Ghaziabad: Fake supplement racket busted, 5 held

    22 medical stores raided in Hisar, 7 stocked dual-use drugs without records

    22 medical stores raided in Hisar, 7 stocked dual-use drugs without records